InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
10 hedge funds and large institutions have $224K invested in InVivo Therapeutics Holdings Corp in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
17% less funds holding
Funds holding: 12 → 10 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
54% less capital invested
Capital invested by funds: $482K → $224K (-$258K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$185K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$161K |
| 3 |
Renaissance Technologies
New York
|
+$124K |
| 4 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
+$10.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$94.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9K |
| 5 |
ICM
IMS Capital Management
Portland,
Oregon
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $78K | +$124K | +873 | +89% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $55K | +$185K | +1,306 | New |
|
|
WS
3
Wedbush Securities
Los Angeles,
California
| $48K | +$161K | +1,138 | New |
|
|
PCM
4
Perkins Capital Management
Wayzata,
Minnesota
| $35K | -$94.4K | -667 | -44% |
|
5
UBS Group
Zurich,
Switzerland
| $4K | +$5.38K | +38 | +63% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $2K | +$6.08K | +43 | New |
|
7
BlackRock
New York
| $1K | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$4.39K | +31 | New |
|
|
9
Vanguard Group
Malvern,
Pennsylvania
| – | -$19K | -115 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | -57 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$9K | -55 | Closed |
|
|
ICM
12
IMS Capital Management
Portland,
Oregon
| – | -$5K | -31 | Closed |
|
13
Northern Trust
Chicago,
Illinois
| – | -$3K | -20 | Closed |
|
14
Geode Capital Management
Boston,
Massachusetts
| – | -$2K | -13 | Closed |
|
|
NC
15
NewSquare Capital
Newtown Square,
Pennsylvania
| – | +$10.5K | +74 | New |
|
NVIV Hedge Fund Activity: Q1 2020 in Review
10 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2020, worth a combined $224K — down 54% from $482K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NVIV and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $185K. The largest seller was Perkins Capital Management, cutting an estimated $94.4K.
- 10 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2020, down from 12 in Q4 2019.
- Funds reported $224K of InVivo Therapeutics Holdings Corp stock for Q1 2020, down 54% quarter-over-quarter.
- 5 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2020 and 6 closed out, a net change of -1 holder.
- The largest InVivo Therapeutics Holdings Corp buyer in Q1 2020 was Sabby Management, an estimated $185K added.
- The largest InVivo Therapeutics Holdings Corp seller in Q1 2020 was Perkins Capital Management, an estimated $94.4K sold.
Based on aggregated 13F filings for Q1 2020.